Evidence map›Paper›PMID 28357237›Full record

ReviewMicrobial cell (Graz, Austria)2014

When less is more: hormesis against stress and disease.

Andreas Zimmermann, Maria A Bauer, Guido Kroemer, Frank Madeo, Didac Carmona-Gutierrez

Abstract readReview
In one paragraph

Review in Microbial cell (Graz, Austria), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. HFE Mutations in Neurodegenerative Disease as a Model of Hormesis.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Reconceptualization of Hormetic Responses in the Frame of Redox Toxicology.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. How Far Are We from Prescribing Fasting as Anticancer Medicine?International journal of molecular sciences · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andreas ZimmermannInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Maria A BauerInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Guido KroemerEquipe 11 Labellisée Ligue Contre le Cancer, INSERM U1138, Centre de Recherche des Cordeliers, 15 Rue de l'École de Médecine, 75006 Paris, France. ; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Pavillon de Recherche 1, 94805 Villejuif, France. ; Université Paris Descartes, Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France. ; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 20 Rue Leblanc, 75015 Paris, France.
Frank MadeoInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Didac Carmona-GutierrezInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.

Funding

Austrian Science Fund FWF I 1000Austrian Science Fund FWF P 23490Austrian Science Fund FWF P 24381
6 · The paper itself

Abstract

All living organisms need to adapt to ever changing adverse conditions in order to survive. The phenomenon termed hormesis describes an evolutionarily conserved process by which a cell or an entire organism can be preconditioned, meaning that previous exposure to low doses of an insult protects against a higher, normally harmful or lethal dose of the same stressor. Growing evidence suggests that hormesis is directly linked to an organism's (or cell's) capability to cope with pathological conditions such as aging and age-related diseases. Here, we condense the conceptual and potentially therapeutic importance of hormesis by providing a short overview of current evidence in favor of the cytoprotective impact of hormesis, as well as of its underlying molecular mechanisms.

Indexed as

aginghormesisneurodegenerationstress resistancetherapeutic preconditioning

Identifiers

PMID28357237
PMCPMC5354599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.